Ohcanbohtosat - Masis Isikbay

  • Čájehuvvo 1 - 3 / 3
Aiddostahte ozu
  1. 1
    Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer

    Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer Dahkki Masis Isikbay, Kristen Otto, Steven Kregel, Jacob Kach, Yi Cai, Donald J. Vander Griend, Suzanne D. Conzen, Russell Z. Szmulewitz

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer

    Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer Dahkki Steven Kregel, James L. Chen, Westin R. Tom, Venkatesh Krishnan, Jacob Kach, Hannah Brechka, Tim Fessenden, Masis Isikbay, Gladell P. Paner, Russell Z. Szmulewitz, Donald J. Vander Griend

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Perineural Invasion and Risk of Lethal Prostate Cancer

    Perineural Invasion and Risk of Lethal Prostate Cancer Dahkki Piotr Zareba, Richard Flavin, Masis Isikbay, Jennifer R. Rider, Travis Gerke, Stephen P. Finn, Andreas Pettersson, Francesca Giunchi, Robert Unger, Alex M. Tinianow, Swen-Olof Andersson, Ove Andrén, Katja Fall, Michelangelo Fiorentino, Lorelei A. Mucci

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: